The Trump administration’s rescheduling order moved FDA-approved marijuana drug products and certain state-regulated medical marijuana products from Schedule I to Schedule III. But for Americans who grow their own at home, the most basic question, did anything actually change for me?, depends entirely on which cannabis attorney you ask. We asked four. They disagree. On… Keep Reading
On April 23, 2026, the Trump administration moved medical marijuana from Schedule I to Schedule III — the biggest federal cannabis policy shift in decades. It was historic. It was also incomplete. Tens of thousands of Americans remain incarcerated for cannabis offenses that are now legal in most of the country. Advocates say rescheduling without… Keep Reading
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov poll found that 59% of Americans already supported legalizing marijuana use, and 84% supported legalizing it for medical purposes. The public has been ahead of federal policy for a long time. The data makes clear how far Washington still has… Keep Reading
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products regulated under qualifying state medical marijuana licenses from Schedule I to Schedule III under federal law. If you’re trying to understand what that actually means — for dispensaries, patients, cannabis businesses and federal policy — this is the explainer. For… Keep Reading
The Trump administration is preparing to move cannabis from Schedule I to Schedule III of the Controlled Substances Act as soon as today, according to reporting from Axios. This would mark the most significant federal cannabis policy shift in decades. It is not legalization. Here’s what you need to know right now. As of publication,… Keep Reading
President Trump signed an executive order on April 18 directing the FDA to fast-track review of psychedelic therapies and committing $50 million to ibogaine research. The psychedelics community is cautiously optimistic, and watching closely. President Donald Trump signed an executive order on Saturday directing federal agencies to accelerate research into psychedelic therapies and allocating $50… Keep Reading
Trump just pushed out the attorney general he ordered to expedite marijuana rescheduling and replaced her, for now, with former personal lawyer Todd Blanche. Industry sources say the Schedule III push is still moving, but for cannabis readers the bigger question remains the same: even if it happens, what exactly does rescheduling solve? Pam Bondi… Keep Reading
